TY - JOUR
T1 - Approaches to addressing the rise in obesity levels
AU - Apovian, Caroline M.
AU - Guo, Xi-Rong
AU - Hawley, John A.
AU - Karmali, Shahzeer
AU - Loos, Ruth J. F.
AU - Waterlander, Wilma E.
N1 - Funding Information: C.M.A. is on advisory boards for Altimmune Inc., Cowen and Company LLC, Gelesis Srl., L-Nutra Inc., NeuroBo Pharmaceuticals Inc., Novo Nordisk Inc., Pain Script Corporation, Riverview School, Rhythm Pharmaceuticals and Xeno Biosciences. C.M.A. has received research funding from the NIH, PCORI and GI Dynamics Inc. The other authors declare no competing interests. Publisher Copyright: © 2022, Springer Nature Limited.
PY - 2023/2
Y1 - 2023/2
N2 - Levels of obesity and overweight are increasing globally, with affected individuals often experiencing health issues and reduced quality of life. The pathogenesis of obesity is complex and multifactorial, and effective solutions have been elusive. In this Viewpoint, experts in the fields of medical therapy, adipocyte biology, exercise and muscle, bariatric surgery, genetics, and public health give their perspectives on current and future progress in addressing the rising prevalence of obesity.
AB - Levels of obesity and overweight are increasing globally, with affected individuals often experiencing health issues and reduced quality of life. The pathogenesis of obesity is complex and multifactorial, and effective solutions have been elusive. In this Viewpoint, experts in the fields of medical therapy, adipocyte biology, exercise and muscle, bariatric surgery, genetics, and public health give their perspectives on current and future progress in addressing the rising prevalence of obesity.
UR - http://www.scopus.com/inward/record.url?scp=85143158199&partnerID=8YFLogxK
U2 - https://doi.org/10.1038/s41574-022-00777-1
DO - https://doi.org/10.1038/s41574-022-00777-1
M3 - Article
C2 - 36450930
SN - 1759-5029
VL - 19
SP - 76
EP - 81
JO - Nature reviews. Endocrinology
JF - Nature reviews. Endocrinology
IS - 2
ER -